Результаты лучевой терапии рака шейки матки
Кравец Ольга Александровна, Марьина Лия Анатольевна, Нечушкин Михаил Иванович · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2010
The purpose ofthis study was to analyze clinical outcomes ofcombinedradiotherapy inpatients with cervical cancer with respect to type ofradioactive source for intracavitary irradiation. Follow-up results ofcombinedradiotherapy are presentedfor 551 patients with stage II, III andIV cervical cancer. Distant radiotherapy was the same inall patients, while intracavitary irradiationwas givenusing sources ofmedium (MDR)or high (HDR)dose activity by AGAT-B HDR(60Co)to 277 patients (group 1), 137Cs (SelectronMDR)to 136 patients (group 2)and192Ir (MicroSelectronor GammaMedPlus HDR)to 138 patients (group 3). Clinical assessment ofresponse to combinedradiotherapy with sources ofvarious activities andisoeffective by dose fractionationinpatients with cervical cancer discoveredthat use of192Ir was associatedwith a lower incidence (13.0%)oflate radiationcomplications as comparedwith 60Co (28.8%)or 137Cs (14.7%). Disease-free 5-year survival instage II cervical cancer ingroups receiving 60Co and192Ir was significantly higher (71.8.5 and74.2.3%, respectively)thaningroups receiving irradiationfrom MDRsources (137Cs, 54.8.5). Analysis of5-year disease-free survival inpatients with stage III cervical cancer failedto findany significant differences, the rates being 41.5.7% ingroup 1 (60Co), 43.2.3% ingroup 2 (137Cs)and45.2.4% ingroup 3 (192Ir). Overall survival inpatients with stage IV cervical cancer was significantly higher after use ofHDRsources of192Ir (49.1 5.6%)thaningroup 1 (60Co)(30.0 1.0%)or 2 (137Cs)(0). Therefore, applicationofup-to-date computedtechnologies inplanning radiotherapy using 192Ir leads to reductioninincidence ofradiotherapy complications with compatible survival rates inpatients with stage II to IV cervical cancer.
Cited by 0 works.